This clinical practice guideline document from the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociacion Latinoamericana de Torax updates prior guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF.
The guidelines include, but are not limited to:
Pulmonary Fibrosis and PDE4B – Video
Identification and Management of ILD in Systemic Sclerosis - Article
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article